277 related articles for article (PubMed ID: 33995482)
1. Identification of Hub Genes and Their Correlation With Immune Infiltration Cells in Hepatocellular Carcinoma Based on GEO and TCGA Databases.
Huang R; Liu J; Li H; Zheng L; Jin H; Zhang Y; Ma W; Su J; Wang M; Yang K
Front Genet; 2021; 12():647353. PubMed ID: 33995482
[TBL] [Abstract][Full Text] [Related]
2. Identification and validation of real hub genes in hepatocellular carcinoma based on weighted gene co-expression network analysis.
Qiao Y; Yuan F; Wang X; Hu J; Mao Y; Zhao Z
Cancer Biomark; 2022; 35(2):227-243. PubMed ID: 36120772
[TBL] [Abstract][Full Text] [Related]
3. Identification of Crucial Genes Associated With Immune Cell Infiltration in Hepatocellular Carcinoma by Weighted Gene Co-expression Network Analysis.
Wang D; Liu J; Liu S; Li W
Front Genet; 2020; 11():342. PubMed ID: 32391055
[TBL] [Abstract][Full Text] [Related]
4. Identification of Hub Genes Associated With Immune Infiltration and Predict Prognosis in Hepatocellular Carcinoma via Bioinformatics Approaches.
Chen H; Wu J; Lu L; Hu Z; Li X; Huang L; Zhang X; Chen M; Qin X; Xie L
Front Genet; 2020; 11():575762. PubMed ID: 33505422
[TBL] [Abstract][Full Text] [Related]
5. Identification of uterine leiomyosarcoma-associated hub genes and immune cell infiltration pattern using weighted co-expression network analysis and CIBERSORT algorithm.
Shen X; Yang Z; Feng S; Li Y
World J Surg Oncol; 2021 Jul; 19(1):223. PubMed ID: 34321013
[TBL] [Abstract][Full Text] [Related]
6. Identification of transcriptome characteristics of granulosa cells and the possible role of UBE2C in the pathogenesis of premature ovarian insufficiency.
Liu D; Guan X; Liu W; Jia Y; Zhou H; Xi C; Zhao M; Fang Y; Wu L; Li K
J Ovarian Res; 2023 Oct; 16(1):203. PubMed ID: 37848988
[TBL] [Abstract][Full Text] [Related]
7. Hub gene identification and immune infiltration analysis in hepatocellular carcinoma: Computational approach.
Pulakuntla S; Singh SA; Reddy VD
In Silico Pharmacol; 2024; 12(1):39. PubMed ID: 38721057
[TBL] [Abstract][Full Text] [Related]
8. Identification of hub genes associated with bladder cancer using bioinformatic analyses.
Zheng W; Zhao Y; Wang T; Zhao X; Tan Z
Transl Cancer Res; 2022 May; 11(5):1330-1343. PubMed ID: 35706790
[TBL] [Abstract][Full Text] [Related]
9. High expression of PDZ-binding kinase is correlated with poor prognosis and immune infiltrates in hepatocellular carcinoma.
Mu W; Xie Y; Li J; Yan R; Zhang J; Liu Y; Fan Y
World J Surg Oncol; 2022 Jan; 20(1):22. PubMed ID: 35065633
[TBL] [Abstract][Full Text] [Related]
10. Identification of Biomarkers Related to Immune Cell Infiltration in Hepatocellular Carcinoma Using Gene Co-Expression Network.
Zhou W; Chen Y; Luo R; Li Z; Jiang G; Ou X
Pathol Oncol Res; 2021; 27():601693. PubMed ID: 34257558
[TBL] [Abstract][Full Text] [Related]
11. Identification of hub genes involved in the occurrence and development of hepatocellular carcinoma via bioinformatics analysis.
Mi N; Cao J; Zhang J; Fu W; Huang C; Gao L; Yue P; Bai B; Lin Y; Meng W; Li X
Oncol Lett; 2020 Aug; 20(2):1695-1708. PubMed ID: 32724412
[TBL] [Abstract][Full Text] [Related]
12. Global analysis of gene expression signature and diagnostic/prognostic biomarker identification of hepatocellular carcinoma.
Wang J; Wang Y; Xu J; Song Q; Shangguan J; Xue M; Wang H; Gan J; Gao W
Sci Prog; 2021; 104(3):368504211029429. PubMed ID: 34315286
[TBL] [Abstract][Full Text] [Related]
13. Screening Hub Genes as Prognostic Biomarkers of Hepatocellular Carcinoma by Bioinformatics Analysis.
Zhou Z; Li Y; Hao H; Wang Y; Zhou Z; Wang Z; Chu X
Cell Transplant; 2019 Dec; 28(1_suppl):76S-86S. PubMed ID: 31822116
[TBL] [Abstract][Full Text] [Related]
14. Identification of oncogenes and tumor-suppressor genes with hepatocellular carcinoma: A comprehensive analysis based on TCGA and GEO datasets.
Zhu Y; Wang Y; Hu M; Lu X; Sun G
Front Genet; 2022; 13():934883. PubMed ID: 36685860
[No Abstract] [Full Text] [Related]
15. CCNB2, CDC20, AURKA, TOP2A, MELK, NCAPG, KIF20A, UBE2C, PRC1, and ASPM May Be Potential Therapeutic Targets for Hepatocellular Carcinoma Using Integrated Bioinformatic Analysis.
Yang Z; Wu X; Li J; Zheng Q; Niu J; Li S
Int J Gen Med; 2021; 14():10185-10194. PubMed ID: 34992437
[TBL] [Abstract][Full Text] [Related]
16. Identification of immune-infiltrating cell-related biomarkers in hepatocellular carcinoma based on gene co-expression network analysis.
Hou Y; Zhang G
Diagn Pathol; 2021 Jul; 16(1):57. PubMed ID: 34218795
[TBL] [Abstract][Full Text] [Related]
17. Integrated Bioinformatics Analysis for the Screening of Hub Genes and Therapeutic Drugs in Hepatocellular Carcinoma.
Su Q; Li W; Zhang X; Wu R; Zheng K; Zhou T; Dong Y; He Y; Wang D; Ran J
Curr Pharm Biotechnol; 2023; 24(8):1035-1058. PubMed ID: 35762549
[TBL] [Abstract][Full Text] [Related]
18. Identification of the hub and prognostic genes in liver hepatocellular carcinoma
Gao Q; Fan L; Chen Y; Cai J
Front Mol Biosci; 2022; 9():1000847. PubMed ID: 36250027
[TBL] [Abstract][Full Text] [Related]
19. Identification of the Tumor Immune Microenvironment and Therapeutic Biomarkers by a Novel Molecular Subtype Based on Aging-Related Genes in Hepatocellular Carcinoma.
Cai D; Zhao Z; Hu J; Dai X; Zhong G; Gong J; Qi F
Front Surg; 2022; 9():836080. PubMed ID: 35392063
[TBL] [Abstract][Full Text] [Related]
20. Identification of CDC20 as an immune infiltration-correlated prognostic biomarker in hepatocellular carcinoma.
Xiong C; Wang Z; Wang G; Zhang C; Jin S; Jiang G; Bai D
Invest New Drugs; 2021 Oct; 39(5):1439-1453. PubMed ID: 33942202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
